Showing results (1-10 of 142) with videos related to
Sort By:
Pageof 15
Hematology. American Society of Hematology. Education Program|December 7, 2019
Moving immunotherapy into the front line in ALLAmanda Winters, Lia GoreBest Practice & Research. Clinical Haematology|December 14, 2022
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALLLia GoreExpert Opinion on Investigational Drugs|September 6, 2011
Entinostat for treatment of solid tumors and hematologic malignanciesJeffrey Knipstein, Lia GoreFrontiers in Oncology|April 19, 2014
Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric ApplicationsLindsey M Hoffman, Lia GoreHaematologica|June 4, 2024
Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemiaKaylyn Utley Lyons, Lia GoreCell|March 29, 2024
Only the beginning: 50 years of progress toward curing childhood cancerLia Gore, Maureen M O'BrienCurrent Hematologic Malignancy Reports|July 20, 2010
Emerging non-transplant-based strategies in treating pediatric non-Hodgkin's lymphomaLia Gore, Tanya M TrippettPaediatric Drugs|November 17, 2017
Agents in Development for Childhood Acute Lymphoblastic LeukemiaKelly W Maloney, Lia GorePaediatric Drugs|March 19, 2014
Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemiaKelly Faulk, Lia Gore, Todd CooperInvestigational New Drugs|November 4, 2010
Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agentsMargaret E Macy, Deborah DeRyckere, Lia GorePageof 15